2021-02-23T07:57:07-06:00 2020-06-30 390859910 BAKER TILLY US LLP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2019-07-01 453533828 BIOBAT INC BIOB 3477991477 450 CLARKSON AVENUE BROOKLYN NY 11203 CRAIG P CAMPBELL TREASURER 3477991477 2021-02-22 1 KERRI N BOGDA CPA P00760402 7177404863 2019 2022-09-23 18:48:47Z EVA CRAMER PHD 450 CLARKSON AVENUE BROOKLYN NY 11203 3543927 0 X WWW.BIOBAT.NYC X 2010 NY DEVELOP SPACE FOR NEW & GROWING BIOPHARM TECH COMPANIES TO CREATE A 21ST CENTURY WORKING WATERFRONT. 10 10 5 10 0 0 128927 4450 2176668 3502679 0 0 1708 36798 2307303 3543927 0 0 0 0 248986 312541 0 0 0 2807378 2515097 3056364 2827638 -749061 716289 47760979 26658147 317219 325360 47443760 26332787 X BIOBAT, A JOINT PARTNERSHIP, CREATED BY THE RESEARCH FOUNDATION FOR SUNY, ON BEHALF OF DOWNSTATE HEALTH SCIENCES UNIVERSITY, AND THE NEW YORK CITY ECONOMIC DEVELOPMENT, PROVIDES:- SOPHISTICATED RESEARCH, OFFICE AND MANUFACTURING SPACE FOR LOCAL, NATIONAL AND INTERNATIONAL BIOTECHNOLOGY AND RELATED COMPANIES- THE OPPORTUNITY TO WORK WITH SUNY DOWNSTATE SCIENTISTS/CLINICIANS/STUDENTS TO ADVANCE THEIR DISCOVERIES AND PERFORM CLINICAL TRIALS- EDUCATIONAL, ENTREPRENEURIAL AND JOB TRAINING OPPORTUNITIES- AN ECONOMIC ENGINE TO CREATE JOBS, ADVANCE KNOWLEDGE AND BRING MEDICAL TREATMENTS AND NEW TECHNOLOGIES TO THE MARKETPLACE. 0 0 2569315 3502679 BIOBAT HOLDS A LEASE INTEREST IN A PORTION OF THE BROOKLYN ARMY TERMINAL AND IS COMMITTED TO CREATING A 21ST CENTURY WORKING WATERFRONT. THUS FAR GOVERNMENT FUNDING HAS ALLOWED BIOBAT TO ACQUIRE, MAINTAIN AND DEVELOP THIS LEASEHOLD INTEREST, AS WELL AS DEVELOP SPACE FOR INNOVATIVE COMPANIES TO APPLY FOR OCCUPANCY AND ENTER INTO LEASES FOR SPACE. BY PROVIDING THESE FACILITIES AND RELATED SUPPORT FOR THE APPLICATION, EXPANSION AND COMMERCIALIZATION OF BIOTECHNOLOGY, LIFE SCIENCES, AND HARD SCIENCES RESEARCH AT THE BROOKLYN ARMY TERMINAL, BIOBAT FULFILLS ITS MISSION. THE DEVELOPMENT OF THE SPACE AT BIOBAT IS BEING DONE IN PHASES. PHASE I IS COMPLETE AND FULLY OCCUPIED. PHASE II IS IN DEVELOPMENT, WITH ONE CURRENT TENANT AND 60,000 SQUARE FEET OF SPACE READY FOR DEVELOPMENT. BIOBAT IS IN NEGOTIATIONS WITH SEVERAL POTENTIAL TENANTS TO LEASE THE REMAINDER OF THE SPACE. 2569315 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 X 5 0 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 NY X JOE SYMOUN 3477991477 140 58TH ST BLDG A BOX 194 BROOKLYN BROOKLYN NY 11220 X KATHLEEN OTTO EXECUTIVE DIRECTOR 55.00 0.00 X 165000 0 23751 EVA CRAMER PHD PRESIDENT 10.00 0.00 X 0 0 0 DR WAYNE RILEY MD CHAIRMAN 1.00 0.00 X X 0 0 0 CRAIG CAMPBELL TREASURER 2.00 0.00 X 0 0 0 JOAN BARTOLOMEO DIRECTOR 1.00 0.00 X 0 0 0 CHRISTINA DEROSE DIRECTOR 1.00 0.00 X 0 0 0 DR JAMES DIAS DIRECTOR 1.00 0.00 X 0 0 0 JEFF GAMBRELL DIRECTOR AS OF 1/1/2020 2.00 0.00 X 0 0 0 AMIT GOLDER DIRECTOR TO 6/30/2020 1.00 0.00 X 0 0 0 MATT KWATINETZ DIRECTOR TO 10/30/2019 1.00 0.00 X 0 0 0 MATT MROZ DIRECTOR 1.00 0.00 X 0 0 0 DR PREM PREMSRIRUT MD DIRECTOR 1.00 0.00 X 0 0 0 DOUG THIEDE DIRECTOR 1.00 0.00 X 0 0 0 CARLO YUVIENCO PHD DIRECTOR 1.00 0.00 X 0 0 0 165000 0 23751 0 0 0 1 0 4450 4450 RENTAL INCOME 532000 1912135 1912135 REIMBURSED EXPENSES 532000 1590544 1590544 3502679 OTHER INCOME 900099 36798 36798 36798 3543927 3502679 0 36798 188751 172250 16501 78241 78241 45549 38619 6930 46019 46019 175 175 3525 3525 9412 8071 1341 6234 5611 623 720150 648135 72015 154 154 536 536 684937 684937 133825 133760 65 COMMON AREA MAINTENANCE 538369 538369 REPAIRS AND MAINTENANCE 364134 327721 36413 SUPPLIES - BUILDING 6898 6898 AGENCY FEES 729 729 2827638 2569315 258323 0 1651633 1500319 804908 513829 255099 509857 320095 300930 25220371 3153159 44305029 22067212 424215 1766000 47760979 26658147 234144 156804 83075 168556 317219 325360 X 47443760 26332787 47443760 26332787 47760979 26658147 X 716289 -21827262 X X 0 1 X 1 0 X 742094 128927 4450 875471 1206728 1816098 1550101 2176668 3502679 10252274 1206728 1816098 2292195 2305595 3507129 11127745 0 0 0 11127745 76 76 76 76 20918 1708 36798 59424 1227646 1816098 2292271 2307303 3543927 11187245 0.99470 0.96160 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2015 AMOUNT: $ 20,918. 2019 AMOUNT: $ 36,798. INSURANCE CLAIMS - 2018 AMOUNT: $ 1,708. 18622734 2701011 15921723 6021397 41783 5979614 37537 17202 20335 538703 393163 145540 22067212 DEPOSITS 190251 RENT RECEIVABLE 389673 DUE FROM NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION 1186076 1766000 TENANT DEPOSITS 168556 168556 X 7259127 3715200 3715200 3543927 0 3543927 6542838 3715200 3715200 2827638 0 2827638 PART X, LINE 2: MANAGEMENT HAS EVALUATED THE CORPORATION'S TAX POSITIONS AND CONCLUDED THAT THE CORPORATION HAS NOT TAKEN ANY UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF ASC 740. X 0 0 0 0 0 0 0 0 0 KATHLEEN OTTO EXECUTIVE DIRECTOR 165000 0 0 0 0 0 13120 0 10631 0 188751 0 0 0 PART VII: THE EXECUTIVE DIRECTOR IS COMPENSATED FROM THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK. FORM 990, PART VI, SECTION A, LINE 6 THE CORPORATION SHALL CONSIST OF TWO (2) MEMBERS: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, FOR THE BENEFIT OF SUNY DOWNSTATE MEDICAL CENTER, ("RESEARCH FOUNDATION") AND NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION ("EDC"). WHILE THE RESEARCH FOUNDATION SHALL ACT FOR THE BENEFIT OF SUNY DOWNSTATE MEDICAL CENTER, THE RESEARCH FOUNDATION SHALL MAINTAIN THE MEMBERSHIP POWERS AND INTEREST, ALONG WITH NYCEDC. EACH MEMBER SHALL REMAIN A MEMBER UNTIL THE MEMBERSHIP TERMINATES BY RESIGNATION OR DISSOLUTION OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 7A IN ACCORDANCE WITH THE BYLAWS OF THE ORGANIZATION, THE BOARD OF DIRECTORS SHALL BE APPOINTED BY THE CORPORATE MEMBERS. FOUR OF THE DIRECTORS SHALL BE NAMED BY THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, FOUR SHALL BE NAMED BY THE NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION AND TWO SHALL BE ELECTED JOINTLY BY THE MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS MADE AVAILABLE TO THE BOARD AND 990 IS REVIEWED BY THE AUDIT COMMITTEE. FORM 990, PART VI, SECTION B, LINE 12C EACH TRUSTEE, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS SHALL ANNUALLY SIGN A STATEMENT WHICH AFFIRMS SUCH PERSON: (A) HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY; (B) HAS READ AND UNDERSTANDS THE POLICY; (C) HAS AGREED TO COMPLY WITH THE POLICY; AND (D) UNDERSTANDS THE CORPORATION IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. TO ENSURE THE CORPORATION OPERATES IN A MANNER CONSISTENT WITH CHARITABLE PURPOSES AND DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS TAX-EXEMPT STATUS, PERIODIC REVIEWS SHALL BE CONDUCTED BY THE AUDIT COMMITTEE. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTOR IS COMPENSATED FROM THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK WHICH IS APPROVED BY THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: LOSS ON DISPOSAL OF LHI - RETURN OF PREMISES -21,827,262. FORM 990, PART XI, LINE 9, CHANGES IN NET ASSETS: IN CONNECTION WITH THE EXECUTION AND DELIVERY OF THIS AMENDMENT, BIOBAT RETURNED A PORTION OF THE ORIGINAL PREMISES, INCLUDING FLOORS FOUR THROUGH EIGHT, PASSENGER ELEVATOR, ALL ELEVATOR SHAFTS, CONSISTING OF APPROXIMATELY 280,000 GROSS SQUARE FEET OF THE ORIGINAL PREMISES. THESE PREMISES WILL NO LONGER BE LEASED TO BIOBAT. AS A RESULT OF THE RETURNED PREMISES, $21,827,262 WAS REMOVED FROM LEASEHOLD IMPROVEMENTS AND RECORDED AS A LOSS ON DISPOSAL DURING THE YEAR ENDED JUNE 30, 2020.